# Cognitive REmediation After Trauma Exposure Trial = CREATE Trial

> **NCT01416948** · PHASE2 · TERMINATED · sponsor: **INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium** · enrollment: 32 (actual)

## Conditions studied

- Posttraumatic Stress Disorder
- Traumatic Brain Injury

## Interventions

- **DRUG:** Methylphenidate Hydrochloride 20 mg
- **DRUG:** Placebo Capsule
- **DRUG:** Galantamine 12 mg

## Key facts

- **NCT ID:** NCT01416948
- **Lead sponsor:** INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-08
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** The funding agency, DoD, determined that the study could not meet its enrollment numbers by the end of the grant.
- **Last updated:** 2013-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01416948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01416948, "Cognitive REmediation After Trauma Exposure Trial = CREATE Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01416948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*